Inhibition of the Proteasome beta2 Site Sensitizes Triple-Negative Breast Cancer Cells to beta5 Inhibitors and Suppresses Nrf1 Activation
Journal article published in 2017 by
E. S. Weyburne,
O. M. Wilkins,
Z. Sha,
D. A. Williams,
A. A. Pletnev,
Bruin G. De,
H. S. Overkleeft 
,
A. L. Goldberg,
Cole,
A. F. Kisselev
,
A. L. Goldberg,
Cole,
A. F. Kisselev
